Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TBS in Treatment-Resistant Depression
NCT07529574Not yet recruiting
- Start
- May 2026
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
Randomised, single-blind trial in major depressive disorder (MDD) (2 arms). Primary endpoint: Hamilton Depression Rating Scale at 2 weeks. Planned start May 2026; status: not yet recruiting.
02
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT07529574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07529574.